BMI View: The UAE will continue to be an attractive emerging market for pharmaceutical companies as a
result of continued investment into the country’s healthcare sector. The rising prevalence of chronic
diseases, such as diabetes, is prompting both the public and private sector to improve the population’s
access to healthcare services – this will act as the main driver of pharmaceutical expenditure in the UAE.
However, during this period of oil price-driven austerity, the government is more likely to cut back
spending on higher-value innovative drugs, posing a risk to multinational drugmakers.
Headline Expenditure Projections
? Pharmaceuticals: AED9.46bn (USD2.58bn) in 2014 to AED10.32bn (USD2.81bn) in 2015; +9.1% in
local currency terms and +9.2% US dollar terms. Forecast unchanged from last quarter.
? Healthcare: AED49.88bn (USD13.58bn) in 2014 to AED52.64bn (USD14.34bn) in 2015; +5.5% in
local currency terms and 5.6% in US dollar terms. Forecast revised upwards from last quarter.

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (United Arab Emirates 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (United Arab Emirates 2011-2019) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2011-2019) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2011-2019) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2011-2019) 19
Prescription Drug Market Forecast 20
Table: UAE Healthcare Demand Split By Therapeutic Area 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019) 23
Patented Drug Market Forecast 24
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019) 25
Generic Drug Market Forecast 26
Table: Generic Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019) 28
OTC Medicine Market Forecast 29
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019) 31
Pharmaceutical Trade Forecast 32
Table: Pharmaceutical Trade Data And Forecasts (United Arab Emirates 2013-2019) 34
Table: Pharmaceutical Trade Data And Forecasts local currency (United Arab Emirates 2013-2019) 34
Industry Risk/Reward Index 35
Middle East and Africa Risk/Reward Index - Q1 2016 35
United Arab Emirates Risk/Reward Index 43
Rewards 43
Risks 43
Regulatory Review 45
Regulatory Regime 45
Regulatory Developments 46
Pharmacovigilance 46
Pharmaceutical Advertising 47
Intellectual Property Issues 47
Pricing Regime 50
Pricing And Reimbursement Developments 51
Regional Harmonisation 53
Market Overview 57
Epidemiology 57
Table: UAE Healthcare Demand Split By Therapeutic Area 59
Healthcare Sector 59
Healthcare Sector Developments 61
Table: Healthcare Resources (United Arab Emirates 2009-2014) 64
Table: Healthcare Personnel (United Arab Emirates 2009-2014) 64
Table: Healthcare Activity (United Arab Emirates 2009-2014) 65
Health Insurance 65
Medical Tourism 67
Research & Development 69
Clinical Trials 71
Competitive Landscape 72
Pharmaceutical Sector 72
Table: Abu Dhabi's Top Five Best Selling Drugs In Value Terms By Therapeutic Area 72
Domestic Industry 73
Foreign Industry 75
Recent Company Developments 76
Table: Table: Multinational Market Activity 76
Pharmaceutical Distribution And Retail 77
Recent Developments 78
Company Profile 79
Gulf Pharmaceutical Industries (Julphar) 79
Neopharma 83
Demographic Forecast 86
Demographic Outlook 86
Table: Population Headline Indicators (United Arab Emirates 1990-2025) 87
Table: Key Population Ratios (United Arab Emirates 1990-2025) 87
Table: Urban/Rural Population & Life Expectancy (United Arab Emirates 1990-2025) 88
Table: Population By Age Group (United Arab Emirates 1990-2025) 88
Table: Population By Age Group % (United Arab Emirates 1990-2025) 89
Glossary 91
Methodology 93
Pharmaceutical Expenditure Forecast Model 93
Healthcare Expenditure Forecast Model 93
Notes On Methodology 94
Risk/Reward Index Methodology 95
Index Overview 96
Table: Pharmaceutical Risk/Reward Index Indicators 96
Indicator Weightings 97

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (United Arab Emirates 2013-2019)
Table: Pharmaceutical Sales, Historical Data And Forecasts (United Arab Emirates 2011-2019)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2011-2019)
Table: UAE Healthcare Demand Split By Therapeutic Area
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019)
Table: Pharmaceutical Trade Data And Forecasts (United Arab Emirates 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (United Arab Emirates 2013-2019)
Table: UAE Healthcare Demand Split By Therapeutic Area
Table: Healthcare Resources (United Arab Emirates 2009-2014)
Table: Healthcare Personnel (United Arab Emirates 2009-2014)
Table: Healthcare Activity (United Arab Emirates 2009-2014)
Table: Abu Dhabi's Top Five Best Selling Drugs In Value Terms By Therapeutic Area
Table: Table: Multinational Market Activity
Table: Population Headline Indicators (United Arab Emirates 1990-2025)
Table: Key Population Ratios (United Arab Emirates 1990-2025)
Table: Urban/Rural Population & Life Expectancy (United Arab Emirates 1990-2025)
Table: Population By Age Group (United Arab Emirates 1990-2025)
Table: Population By Age Group % (United Arab Emirates 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators